Here’s a thought experiment: take every fact asserted and every quote offered in this article about HGH use and testing in the NFL and replace the proper nouns with baseball players and baseball teams. And then ask yourself how thick the walls would have to be on your backyard shelter to withstand the nuclear fallout from all of the outrage that would come from the sporting press:
As soon as the three letters are mentioned – H-G-H – the player laughs. Human growth hormone? In the NFL? Come on. HGH use is rampant, this NFC starter says. “It’s like clockwork nowadays,” he said, estimating 10-15 players on each team use the banned substance. “Not tested and it’s easy to get. Nowadays, dude? In 2013? (Expletive) yeah. I’m just being real.” …
… Twenty-one months after agreeing to a test, HGH remains a part of the NFL. That’s the cold, unsettling reality. “Until they start testing for it, it’s not illegal, right?” [Darren] Woodson said. “It’s just a dirty game. I’ve always felt it was that way.”
Thing is, a lot of people in that article make good points about the use and efficacy of HGH. But you’re not allowed to talk about that in baseball. Orthodoxy mandates that HGH is evil, squeezed from The Devil’s glands and used only by those of blackest heart. And they turn you from a crappy player to a Hall of Famer overnight. Except the Hall of Fame part, because we won’t have you there if you dare use HGH.
Why does football get to actually talk about this stuff? Why aren’t any sportswriters giving up on football and damning that whole lot to Hell?
Free agent first baseman James Loney has reportedly signed a minor league deal with the Rangers, per FanRag Sports’ Jon Heyman. The deal includes an invite to spring training and a $1 million salary if he makes the major league roster in 2017.
Loney picked up a one-year stint and starting role with the Mets in 2016, slashing .265/.307/.397 with nine home runs in 336 PA. While his numbers were down a hair from the .280/.322/.357 batting line he produced with the Rays in 2015, he provided the Mets with a necessary, if underwhelming upgrade over an injured Lucas Duda through most of the season.
The 32-year-old infielder is expected to have some competition at first base, with at least five other candidates in the mix: Jurickson Profar, Ronald Guzman, Ryan Rua, Joey Gallo and Josh Hamilton. Rumor has it that the team is planning on platooning Rua and Profar in 2017, barring any impressive breakouts or injuries during spring training, though Loney could still provide the club with some veteran depth and a decent left-handed bat off the bench.
Comments from an anonymous team official suggest that Rangers right-hander Tyson Ross will not be expected to join the rotation until May or June, per a report from Jeff Wilson of the Fort Worth Star-Telegram. Both Ross and GM Jon Daniels favor a conservative approach for the 29-year-old as he works his way back up to full health after undergoing surgery last October to relieve thoracic outlet syndrome.
The delay is reportedly being implemented so that Ross will be have the strength and stamina to contribute during the stretch run. Per Daniels:
We would rather err on a little extra time up front with the goal being to finish strong, pitching in big spots, meaningful games down the stretch and hopefully past 162.
Ross signed a one-year deal with the team on Thursday after pitching through an injury-riddled season with the Padres in 2016. If all goes according to plan, he’ll slot into a rotation that includes Yu Darvish, Cole Hamels, Andrew Cashner and Martin Perez. The Rangers are expected to narrow down their fifth starter alternatives in spring training.